Vireo Health International, Inc. (VREOF): Price and Financial Metrics
VREOF Price/Volume Stats
| Current price | $2.40 | 52-week high | $3.84 |
| Prev. close | $2.33 | 52-week low | $0.47 |
| Day low | $2.35 | Volume | 289,500 |
| Day high | $2.52 | Avg. volume | 381,069 |
| 50-day MA | $2.22 | Dividend yield | N/A |
| 200-day MA | $1.87 | Market Cap | N/A |
VREOF Stock Price Chart Interactive Chart >
Vireo Health International, Inc. (VREOF) Company Bio
Vireo Health International, Inc. operates as a cannabis company. The Company produces pharmaceutical-grade cannabis extracts and sells its products to company owned and third-party dispensaries.
Latest VREOF News From Around the Web
Below are the latest news stories about Vireo Health International Inc that investors may wish to consider to help them evaluate VREOF as an investment opportunity.
Vireo Health announces name change to Goodness Growth Holdings; issues FY2022 outlook above consensus in conjunction with its 2021 Investor DayVireo Health ([[VREOF]] +5.2%) announces a series of corporate updates in conjunction with its 2021 Investor Day events; effective June 9, 2021 at market open, its subordinate voting shares will begin trading as Goodness Growth Holdings, under the ticker symbol "GDNS" on the Canadian Securities Exchange and on the OTCQX Market... |
Vireo Health Announces Name Change to Goodness Growth Holdings in Conjunction with 2021 Investor Day EventsVireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), the leading physician-led, science-focused multi-state cannabis company, today announced a series of corporate updates in conjunction with its 2021 Investor Day events. In addition to unveiling its Horizon Strategy and outlook ranges for FY22 revenue and adjusted EBITDA performance, the Company also announced that effective June 9, 2021 at market open, its subordinate voting shares will begin trading as Goodne |
Vireo Health to Host Virtual Investor Day Events on June 8th and June 9thVireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), the leading physician-led, science-focused multi-state cannabis company, today announced that it will host a series of online virtual events for the institutional and retail investment communities on Tuesday, June 8, 2021 and Wednesday, June 9, 2021. |
Vireo Health International misses on revenueVireo Health International (VREOF): Q1 GAAP EPS of -$0.06.Revenue of $13.2M (+8.9% Y/Y) misses by $0.15M.Press Release... |
Vireo Health to Report First Quarter 2021 Results on May 14, 2021Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO, OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced that it will report financial results for its first quarter ended March 31, 2021 on Friday, May 14, 2021 before the market opens. |
VREOF Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 100.00% |
| 5-year | N/A |
| YTD | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 38.27% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...